Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04870112
Title A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCope-D1)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca

lung non-small cell carcinoma

lung small cell carcinoma


Carboplatin + Cisplatin + Durvalumab + Etoposide


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.